EU Critical Medicines Act: closer to ending overreliance on Asian manufacturers
China's virtual monopoly on the supply of many APIs could be dangerous for the security of medicine supply to Western countries.
In Association With 3M
Enabling process intensification in biopharma manufacturing
Optimising biopharma production through process intensification
Resolving challenges with product recovery in biopharma manufacturing
Overcoming challenges with scalability in biopharma manufacturing
Solving problems with harvest clarification using fibre-based chromatography
